CLSI I/LA29-A:2008

CLSI I/LA29-A:2008

Detection of HLA-Specific Alloantibody by Flow Cytometry and Solid Phase Assays, Proposed Guideline, ILA29AE

193,00 €

Detalles

The current and emerging technologies for detecting and characterizing human leukocyte antigen (HLA) alloantibodies provide powerful tools for predicting the risk of immunological response to a transplant. Clinical and Laboratory Standards Institute document I/LA29-A--Detection of HLA-Specific Alloantibody by Flow Cytometry and Solid Phase Assays, Approved Guideline describes criteria for optimizing methods that utilize flow cytometry and other conventional and multiplex platforms. The intended audience includes solid organ and stem cell transplant laboratories, manufacturers of systems for histocompatibility testing, and organizations that manage organ sharing.

Información adicional

Autor Clinical and Laboratory Standards Institute (CLSI)
Publicado por CLSI
Tipo de Documento Norma
Tema /subgroups/17902
EAN ISBN 156238676X
Número de páginas 64
Palabra clave CLSI I/LA29-A